AFT Pharmaceuticals Limited (NZX:AFT) Annual Report 2022



The latest annual report of AFT Pharmaceuticals Limited (AFT) was published on 31 Mar 2022. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - AFT Annual Results

Amounts in NZD

Total Revenue
130.31M
Gross Profit
61.77M
EBIT
20.39M
Net Tangible Assets
40.76M
Net Income
19.85M
Capital Expenditures
-329k

AFT Income Statement 2022 Annual Report

As per the latest Income Statement of AFT, the Net revenue increased by $17.21M (15%) compared to the previous period. The operating income in 2022 increased by $9.68M (90%). The net income as per the annual report was 19.85M which increased by $12.07M (155%) compared to previous year.

Income Statement Report (2022/2021)

20222021
Total Revenue130.31M113.11M
Gross Profit61.77M48.74M
Operating Income20.39M10.71M
Income Before Tax18.68M7.89M
Net Income19.85M7.78M

Balance Sheet - AFT 2022 Annual Report

Read further: AFT Balance Sheet Detailed Analysis

The latest balance sheet from annual result of AFT Pharmaceuticals Limited showed the company increased the cash on balance sheet by $4.73M (147%). The Net tangible assets of AFT on the balance sheet were at 40.76M which is $19.76M (94%) more than previous annual report. The total stockholder equity also increased by $20.16M (55%) compared to previous reporting period.

Balance Sheet Statement Report (2022/2021)

20222021
Cash7.94M3.21M
Total Assets121.76M 105.13M
Long Term Debt33.2M33.2M
Total Liabilities65.02M 68.54M
Total Shareholder Equity56.74M36.59M
Net Tangible Assets40.76M21M

Cash Flow Statement - AFT 2022 Annual Report

The 2022 annual cash flow statement of AFT Pharmaceuticals Limited showed that the net income increased by $12.07M (155%) compared to previous reporting period. Also the capital expenditure of AFT decreased by $-236000 (-254%).

As of 2022, the total cash from investing activities was -5.58M and total cash from financing activities was -3.91M.

Cash Flow Statement Report (2022/2021)

20222021
Net Income19.85M7.78M
Capital Expenditures-329k-93k
Dividends Paid--188k
Total Cash From From Investing Activities-5.58M-6.23M
Total Cash From From Financing Activities-3.91M2.52M

AFT Pharmaceuticals Limited Annual Report History

Income Statement

Income Statement history of AFT Pharmaceuticals Limited (NZX:AFT)

31 Mar 202231 Mar 202131 Mar 202031 Mar 2019
Total Revenue130.31M113.11M105.6M85.13M
Cost Of Revenue68.54M64.36M57.33M44.4M
Gross Profit61.77M48.74M48.27M40.73M
Research Development3.62M1.97M1.97M914k
Selling General Administrative37.99M36.69M37.3M35.42M
Non Recurring----
Other Operating Expenses-225k-626k-535k-2.24M
Total Operating Expenses109.92M102.4M94.09M78.49M
Operating Income20.39M10.71M11.5M6.64M
Total Other Income Expense Net-1.7M-2.82M1.38M-8.9M
Ebit20.39M10.71M11.5M6.64M
Interest Expense-2.44M-3.44M-6.96M-5.39M
Income Before Tax18.68M7.89M12.88M-2.26M
Income Tax Expense-1.16M105k185k168k
Minority Interest----
Net Income From Continuing Ops19.85M7.78M12.69M-2.43M
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income19.85M7.78M12.69M-2.43M
Net Income Applicable To Common Shares19.85M7.59M11.7M-3.36M

Balance Sheet Statement

Balance Sheet Statement history of AFT Pharmaceuticals Limited (NZX:AFT)

31 Mar 202231 Mar 202131 Mar 202031 Mar 2019
Cash7.94M3.21M6.12M6.92M
Net Receivables29.87M29.23M22.63M16.28M
Inventory33.5M33.65M22.73M25.16M
Other Current Assets100k-514k-
Total Current Assets77.54M67.9M55.34M51.26M
Property Plant Equipment3.36M3.79M4.03M357k
Intangible Assets15.99M15.59M15.46M2.91M
Other Assets24.87M17.86M12.23M6.03M
Deferred Long Term Asset Charges2.77M724k705k705k
Total Assets121.76M105.13M87.05M63.59M
Accounts Payable12.07M14.7M8.62M6.67M
Short Long Term Debt4M5.16M2M41.75M
Other Current Liab4.33M4M7.39M6.63M
Long Term Debt33.2M33.2M41.2M-
Deferred Long Term Liab22.11M17.13M11.52M5.33M
Total Current Liabilities29.05M32.1M25.1M58.5M
Total Liab65.02M68.54M69.8M58.5M
Common Stock80.77M80.36M57.06M57.06M
Retained Earnings-21.42M-41.26M-49.27M-61.01M
Treasury Stock-2.61M-2.51M-1.32M-1.33M
Other Stockholder Equity-2.61M-2.51M-1.32M-1.33M
Total Stockholder Equity56.74M36.59M6.46M-5.27M
Net Tangible Assets40.76M21M-9M-8.19M

Cash Flow Statement

Cash Flow Statement history of AFT Pharmaceuticals Limited (NZX:AFT)

31 Mar 202231 Mar 202131 Mar 202031 Mar 2019
Net Income19.85M7.78M12.69M-2.43M
Depreciation913k975k956k243k
Change To Netincome732k3.5M82k7.85M
Change To Account Receivables-4.96M-4.56M-7.3M-2.05M
Change To Liabilities-2.66M3.84M5.88M-1.88M
Change To Inventory154k-10.92M2.42M-746k
Total Cash From Operating Activities14.15M750k14.88M1.07M
Capital Expenditures-329k-93k-92k-140k
Total Cashflows From Investing Activities-5.58M-6.23M-6.56M-4.88M
Net Borrowings-2.02M-5.49M-2.65M7.42M
Other Cashflows From Financing Activities-2.19M-4.19M-5.9M-3.56M
Total Cash From Financing Activities-3.91M2.52M-9.12M3.72M
Effect Of Exchange Rate78k49k5k240k
Change In Cash4.73M-2.91M-797k146k
Issuance Of Stock295k12.4M3k3k
Dividends Paid--188k-566k-134k